Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
New air cargo project links medicine and agriculture
The initiative is set to revolutionise healthcare delivery and agricultural exports in low- and middle-income countries.
Read more
Pharma voted second most trusted industry in Britain
The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.
Moderna becomes latest ABPI member
Moderna has become the latest member of the ABPI as part of its long-term commitment to expand in the UK.
HBA names 2023 Woman of the Year
The HBA has named its 2023 Woman of the Year, Honourable Mentor and STAR volunteer leader.
ROI in R&D declines sharply in 2022
Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.
Spotlight: December 2022 - January 2023
GOLD looks back at some of the pharma industry’s recent news.
RSV drug nirsevimab chases FDA approval
A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.
Pharma's sustainability agenda centre stage in new ABPI report
Global action is required to ensure pharma’s commitments to reach Net Zero are realised, according to a new ABPI report.
Pfizer joins GSK in RSV success
Pfizer plans to file for approval for its RSV vaccine for infants by the end of 2022 after achieving positive Phase 3 results.
Loading posts...
« Previous
1
…
21
22
23
24
25
…
27
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View